Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
Memorial Sloan Kettering Cancer Center.
ClinicalTrials.gov Identifier:
NCT01180569
First received: August 10, 2010
Last updated: June 14, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)